Gapping down
In reaction to disappointing earnings/guidance: HYGS -9.8%, NAV -4.4%, KO -1.1%, PAY -0.9%, WHR -0.8%, ELY -0.6%
Select Russia related names showing weakness: CTCM -12.1%, MBT -7.9%, YNDX -6.6%, VIP -5.9%, RSX -4.8%
Select oil/gas related names showing early weakness: LINE -1.3%, NOV -1.3%, COP -1.3%, OXY -1.2%, HAL -1.1%, SLB -1%, ESV -0.8%, XOM -0.5%
Other news: CYCC -47.3% (determined that based on available interim data, it would be unlikely for the study to reach statistically significant improvement in survival ), FRO -13.9% (entered into a private agreement to exchange $22,5 mln of the outstanding principal amount of the Company's 4.5% Convertible Bond Issue 2010/2015), AXAS -8.2% (provided Q4 and FY15 production guidance; co reduced 2015 drilling budget to ~$54 mln from $200 mln due to current commodity price weakness), LPI -6% (announces 2015 capital budget of $525 mln), RDY -5.1% (announces the launch of valganciclovir tablets), WAVX -3.6% (elected David Cote Chairman of the Board), CLF -2.6% (still checking), TSLA -1.3% (still checking), CHK -1.3% (closed on a new five-year, $4 bln senior unsecured revolving credit facility), CELG -1.2% (still checking)
Analyst comments: BAS -3% (downgraded to Sell from Hold at Wunderlich), SFLY -2.6% (downgraded to Neutral from Buy at Goldman), OAS -1.9% (downgraded to Hold from Buy at Wunderlich), MSFT -1.3% (downgraded to Underperform from Neutral at BofA/Merrill), TWTR -0.5% (target lowered to $45 from $55, maintain Buy at Evercore ISI)
In reaction to disappointing earnings/guidance: HYGS -9.8%, NAV -4.4%, KO -1.1%, PAY -0.9%, WHR -0.8%, ELY -0.6%
Select Russia related names showing weakness: CTCM -12.1%, MBT -7.9%, YNDX -6.6%, VIP -5.9%, RSX -4.8%
Select oil/gas related names showing early weakness: LINE -1.3%, NOV -1.3%, COP -1.3%, OXY -1.2%, HAL -1.1%, SLB -1%, ESV -0.8%, XOM -0.5%
Other news: CYCC -47.3% (determined that based on available interim data, it would be unlikely for the study to reach statistically significant improvement in survival ), FRO -13.9% (entered into a private agreement to exchange $22,5 mln of the outstanding principal amount of the Company's 4.5% Convertible Bond Issue 2010/2015), AXAS -8.2% (provided Q4 and FY15 production guidance; co reduced 2015 drilling budget to ~$54 mln from $200 mln due to current commodity price weakness), LPI -6% (announces 2015 capital budget of $525 mln), RDY -5.1% (announces the launch of valganciclovir tablets), WAVX -3.6% (elected David Cote Chairman of the Board), CLF -2.6% (still checking), TSLA -1.3% (still checking), CHK -1.3% (closed on a new five-year, $4 bln senior unsecured revolving credit facility), CELG -1.2% (still checking)
Analyst comments: BAS -3% (downgraded to Sell from Hold at Wunderlich), SFLY -2.6% (downgraded to Neutral from Buy at Goldman), OAS -1.9% (downgraded to Hold from Buy at Wunderlich), MSFT -1.3% (downgraded to Underperform from Neutral at BofA/Merrill), TWTR -0.5% (target lowered to $45 from $55, maintain Buy at Evercore ISI)